Validation of a tandem mass spectrometry method using combined extraction of 37 oxylipins and 14 endocannabinoid-related compounds including prostamides from biological matrices

Prostaglandins and Other Lipid Mediators

Volumn 121, Issue , 2015, Pages 110-121

  Gouveia Figueira, Sandra ^a   Nording, Malin L ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Eicosanoids; Endocannabinoids; Mass spectrometry; Oxylipins; SPE

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; AMIDE; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; ICOSANOID; OXYLIPIN; PROSTAGLANDIN E2;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; COW; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MEASUREMENT ACCURACY; METABOLITE; METABOLOME; MILK; NONHUMAN; PIG; SOLID PHASE EXTRACTION; SPECIES DIFFERENCE; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; ANIMAL; ANTIBODY SPECIFICITY; BOVINE; CHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; METABOLOMICS; PROCEDURES; STATISTICAL MODEL;

ANIMALS; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINOPROSTONE; ENDOCANNABINOIDS; HUMANS; LIMIT OF DETECTION; LINEAR MODELS; METABOLOMICS; MILK; ORGAN SPECIFICITY; OXYLIPINS; SOLID PHASE EXTRACTION; SPECIES SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84949623508     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2015.06.003     Document Type: Article

References (31)

1. A.M. Zivkovic, J. Yang, K. Georgi, and et al. Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations Metabolomics 8 6 2012 1102 1113
2. C.J. Fowler Transport of endocannabinoids across the plasma membrane and within the cell FEBS J 280 9 2013 1895 1904
3. A.A. Zoerner, F.-M. Gutzki, S. Batkai, and et al. Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective Biochim Biophys Acta Mol Cell Biol Lipids 1811 11 2011 706 723
4. D. Balgoma, A. Checa, D.G. Sar, S. Snowden, and C.E. Wheelock Quantitative metabolic profiling of lipid mediators Mol Nutr Food Res 57 8 2013 1359 1377
5. B.P. Roques, M.-C. Fournié-Zaluski, and M. Wurm Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain Nat Rev Drug Discov 11 4 2012 292 310
6. J.P. Schuchardt, S. Schmidt, G. Kressel, and et al. Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men Prostaglandins Leukot Essent Fatty Acids 89 1 2013 19 29
7. J. Häggström, M. Cipriano, L.P. Forshell, and et al. Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray Prostate 74 11 2014 1107 1117
8. A. Wong, D.R. Sagar, C.A. Ortori, D.A. Kendall, V. Chapman, and D.A. Barrett Simultaneous tissue profiling of eicosanoid and endocannabinoid lipid families in a rat model of osteoarthritis J Lipid Res 55 9 2014 1902 1913
9. 2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability PLOS ONE 7 2 2012 e31111
10. A. Weber, J. Ni, K.-H.J. Ling, and et al. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry J Lipid Res 45 4 2004 757 763
11. L. Jean-Gilles, S. Feng, C.R. Tench, and et al. Plasma endocannabinoid levels in multiple sclerosis J Neurol Sci 287 1-2 2009 212 215
12. T.H. Marczylo, P.M.W. Lam, V. Nallendran, A.H. Taylor, and J.C. Konje A solid-phase method for the extraction and measurement of anandamide from multiple human biomatrices Anal Biochem 384 1 2009 106 113
13. L. Lin, H. Yang, and P.J.H. Jones Quantitative analysis of multiple fatty acid ethanolamides using ultra-performance liquid chromatography-tandem mass spectrometry Prostaglandins Leukot Essent Fatty Acids 87 6 2012 189 195
14. A. Ostermann, I. Willenberg, and N. Schebb Comparison of sample preparation methods for the quantitative analysis of eicosanoids and other oxylipins in plasma by means of LC-MS/MS Anal Bioanal Chem 407 5 2015 1403 1414
15. J. Yang, K. Schmelzer, K. Georgi, and B.D. Hammock Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry Anal Chem 81 19 2009 8085 8093
16. D.S. Dumlao, M.W. Buczynski, P.C. Norris, R. Harkewicz, and E.A. Dennis High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines Biochim Biophys Acta Mol Cell Biol Lipids 1811 11 2011 724 736
17. K. Strassburg, D. Esser, R.J. Vreeken, and et al. Postprandial fatty acid specific changes in circulating oxylipins in lean and obese men after high-fat challenge tests Mol Nutr Food Res 58 3 2014 591 600
18. D. Grapov, S.H. Adams, T.L. Pedersen, W.T. Garvey, and J.W. Newman Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids PLOS ONE 7 11 2012 e48852
19. F. Shono, K. Yokota, K. Horie, and et al. A heterologous enzyme immunoassay of prostaglandin E2 using a stable enzyme-labeled hapten mimic Anal Biochem 168 2 1988 284 291
20. C. Fischer, and J.C. Frölich P. Rodolfo, K. David, Advances in Lipid Research 1982 Elsevier 185 202
21. J. Song, X. Liu, J. Wu, and et al. A highly efficient, high-throughput lipidomics platform for the quantitative detection of eicosanoids in human whole blood Anal Biochem 433 2 2013 181 188
22. M.S. Gachet, P. Rhyn, O.G. Bosch, B.B. Quednow, and J. Gertsch A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma, J Chromatogr B 976-977 2015 6 18
23. Y. Wang, A.M. Armando, O. Quehenberger, C. Yan, and E.A. Dennis Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples J Chromatogr A 1359 2014 60 69
24. S. Gouveia-Figureia, J. Späth, A.M. Zivkovic, and M.L. Nording Profiling the oxylipin and endocannabinoid metabolome by UPLC-ESI-MS/MS in human plasma to monitor postprandial inflammation PLOS ONE 10 7 2015 e0132042 10.1371/journal.pone.0132042
25. S. Gouveia-Figueira, and M.L. Nording Development and validation of a sensitive UPLC-ESI-MS/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids Anal Chem 86 2 2013 1186 1195
26. Administration, U.S.F.a.D., 2001
27. I. Willenberg, A. Ostermann, and N. Schebb Targeted metabolomics of the arachidonic acid cascade: current state and challenges of LC-MS analysis of oxylipins Anal Bioanal Chem 407 10 2015 2675 2683
28. D. Richardson, C.A. Ortori, V. Chapman, D.A. Kendall, and D.A. Barrett Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry Anal Biochem 360 2 2007 216 226
29. D.J. Liput, E. Tsakalozou, D.C. Hammell, K.S. Paudel, K. Nixon, and A.L. Stinchcomb Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography-electrospray mass spectroscopy J Pharm Anal 4 4 2014 234 241
30. D. Panigrahy, B.T. Kalish, S. Huang, and et al. Epoxyeicosanoids promote organ and tissue regeneration Proc Natl Acad Sci 110 33 2013 13528 13533
31. M.W. Buczynski, and L.H. Parsons Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls Br J Pharmacol 160 3 2010 423 442